Business description: INSTEM

Number of employees: 510
Sales by Activity: INSTEM
| Fiscal Period: December | 2021 (GBP) | 2022 (GBP) | 2023 (GBP) | 2024 (GBP) | 2025 (GBP) |
|---|---|---|---|---|---|
Clinical Trial Acceleration (CTA) | 12.71M | 17.42M | - | - | - |
Silico Translational Services (ISTS) | 3.04M | 3.78M | - | - | - |
Regulatory Solutions | 10.01M | 12.03M | - | - | - |
Study Management | 20.26M | 25.65M | - | - | - |
Geographical breakdown of sales: INSTEM
| Fiscal Period: December | 2021 (GBP) | 2022 (GBP) | 2023 (GBP) | 2024 (GBP) | 2025 (GBP) |
|---|---|---|---|---|---|
USA | 26.83M | 35.19M | 36.5M | 32.69M | - |
Rest of World | 8.17M | 11.55M | 11.44M | 11.39M | - |
Rest of Europe | 7.48M | 8.85M | 9.58M | 8.26M | - |
United Kingdom | 3.54M | 3.3M | 2.85M | 2.92M | - |
Executive Committee: INSTEM
| Manager | Title | Age | Since |
|---|---|---|---|
Vik Krishnan
CEO | Chief Executive Officer | - | 2024-07-31 |
Joel Hooper
COO | Chief Operating Officer | - | - |
Vince D’Angelo
CMP | Compliance Officer | - | - |
Mark Poggi
SAM | Sales & Marketing | - | 2022-12-31 |
John L. Alarcon
PRN | Corporate Officer/Principal | - | - |
Composition of the Board of Directors: INSTEM
| Director | Title | Age | Since |
|---|---|---|---|
David Gare
CHM | Chairman | 83 | 2010-10-20 |
Mike McGoun
BRD | Director/Board Member | 78 | 2010-10-21 |
Riaz Bandali
BRD | Director/Board Member | 57 | 2021-11-30 |
Mary Dolson
BRD | Director/Board Member | - | 2023-01-08 |
Company details: INSTEM

















